glp 1 meds and alzheimer's Popular obesity drug fails in hotly anticipated trials | Science Prevention of Dementia with GLP-1

Semaglutide acts like human glucagon-like peptide-1 (GLP-1), in that it increases insulin secretion which thereby increases sugar metabolism

Effects of Glucagon Like Peptide-1 Receptor Agonists on Endocrine Metabolism Interestingly, GLP-1RAs not only exert a protective effect on the nervous and cardiovascular systems, but also exhibit a regulatory effect on metabolism

The testing that grey market communities perform is better than nothing, but dramatically short of what would be required for a product intended for injection into a human body

While both medications mimic natural gut hormones that regulate appetite, they differ in interaction with bodys receptors

doi:10.1111/1462-2920.13589

Conditions That May Defer Blood Donation While on GLP-1 Therapy Blood banks may defer donors with poorly controlled diabetes, regardless of whether they take GLP-1 medications